Premature acute coronary syndrome: understanding the early onset
Raquel Menezes Fernandes1,2, Teresa Mota1,2, Hugo Costa1,2
1Cardiology Deparment, Centro Hospitalar Universitário do Algarve.
Insights
Premature acute coronary syndrome (ACS) affects 25% of patients, often presenting as STEMI but with better outcomes. Prevention focusing on modifiable risk factors is crucial for reducing coronary events.
Area of Science:
- Cardiology
- Public Health
Background:
- Acute coronary syndrome (ACS) is increasingly recognized as a significant health issue in younger adults.
- Modifiable cardiovascular risk factors contribute to the rising prevalence of ACS in this demographic.
Purpose of the Study:
- To characterize patients experiencing premature ACS.
- To compare the clinical profiles and outcomes of premature ACS patients with those of non-premature ACS patients.
Main Methods:
- A retrospective analysis of 29,870 patients from the Portuguese Registry (ProACS).
- Patients were categorized into premature ACS (men <55, women <65 years) and non-premature ACS groups.
- The primary endpoint included in-hospital mortality, stroke, and myocardial reinfarction (re-MI).
Main Results:
- 25% of patients had premature ACS, with a mean age of 50 years.
- Premature ACS patients exhibited higher rates of smoking, obesity, and dyslipidemia.
- ST-segment elevation myocardial infarction (STEMI) was more common in younger patients, who also had a lower Killip-Kimball class and preserved left ventricular ejection fraction (LVEF).
- The composite endpoint was more frequent in non-premature ACS patients.
- Younger patients had lower in-hospital mortality, re-MI, stroke rates, and 1-year mortality and readmissions.
Conclusions:
- Premature ACS, while affecting 25% of the ACS population and often presenting as STEMI, is generally associated with a better clinical course.
- Effective prevention strategies targeting modifiable cardiovascular risk factors are essential to mitigate coronary events in younger populations.
Introduction:
Acute coronary syndrome (ACS) is less frequent in young adults, but it has become a significant health problem, associated with the increasing prevalence of modifiable risk factors.
Objectives:
To characterize patients admitted with premature ACS, comparing with those with nonpremature ACS.
Methods:
We performed a retrospective study encompassing patients of the Portuguese Registry (ProACS), comparing two groups: one composed of men less than 55 and women less than 65 years old; and other with men ≥55 and women ≥65 years old at the ACS admission. The primary endpoint was the composite of in-hospital mortality, stroke and myocardial reinfarction (re-MI).
Results:
A total of 29 870 patients were enrolled and 25% had premature ACS, with a mean age of 50 ± 7 years old. They had a larger prevalence of smoking habits, obesity and dyslipidemia. ST-segment elevation MI (STEMI) was the main admission diagnosis in young patients and coronary angiogram mainly revealed one vessel disease in this subgroup. They had a lower Killip-Kimball (KK) class and mostly preserved left ventricular ejection fraction (LVEF). Composite endpoint was more frequent in nonpremature ACS patients. Nonpremature age, presentation with syncope or cardiac arrest, KK class >1, multivessel disease and LVEF <40% were independent predictors of the primary endpoint ( P < 0.001). Younger patients had lower rates of in-hospital all-cause mortality, re-MI and stroke. One-year all-cause mortality and 1-year cardiovascular and non-cardiovascular readmissions were also lower.
Conclusions:
Premature ACS affects 25% of the ACS population, mostly presenting with STEMI, but generally associated with better clinical evolution. Nevertheless, prevention measures are essential to correct modifiable cardiovascular risk factors and reduce coronary events.
More Related Videos
06:39Intracoronary Acetylcholine Provocation Testing for Assessment of Coronary Vasomotor Disorders
Published on: August 18, 2016
08:51Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts
Published on: September 20, 2024
Related Concept Videos
Acute Coronary Syndrome III: Diagnostic Studies
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome IV: Interprofessional Care
Acute Coronary Syndrome V: Nursing Management
Coronary Artery Disease I: Introduction
